Skip to main content
RNA
NASDAQ Life Sciences

Atrium Therapeutics Posts 25-Cent Quarterly Loss as Cash Burn Draws Scrutiny

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.56
Mkt Cap
$167.07M
52W Low
$7.49
52W High
$16.77
52W Position info
0.9% above low
Off High info
55% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

RNA is trading near its 52-week low of $7.49 (0.9% above the low).

Summary

Atrium Therapeutics reported a third-quarter loss of 25 cents a share, or $4.27 million. The company is trading near its 52-week low of $7.49, so the print lands on a stock already under pressure. This follows the $50 million PIPE priced at $7.93 a share in October and Yakira Capital's public push for a strategic review and spending cuts. The loss keeps the focus on burn rate, with cash runway now extending through 2028, and third-quarter collaboration revenue rose on a BMS milestone. The Corventis Phase 1/2 trial of ATR 1072, which dosed its first patient in late October, is the main clinical item on the calendar.

At the time of this announcement, RNA was trading at $7.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $167.1M. The 52-week trading range was $7.49 to $16.77. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

RNA - Latest Insights

RNA
Oct 20, 2026, 8:09 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $7.72
Real-time Price: $7.51 info
Change: -$0.210 (-3%) info
Market Cap: $167.293M info
RNA
Oct 08, 2026, 6:52 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.93
Real-time Price: $7.51 info
Change: -$0.420 (-5%) info
Market Cap: $167.293M info
RNA
Oct 08, 2026, 6:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $7.93
Real-time Price: $7.51 info
Change: -$0.420 (-5%) info
Market Cap: $167.293M info
RNA
Jul 14, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $12.22
Real-time Price: $7.51 info
Change: -$4.71 (-39%) info
Market Cap: $167.293M info
RNA
Jul 14, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.22
Real-time Price: $7.51 info
Change: -$4.71 (-39%) info
Market Cap: $167.293M info